Back
L'Oreal SA Vs. Spyre Therapeutics Industry Stock Comparison
Sell
42
LRLCY
L'Oreal SA
Last Price:
77.39
Seasonality Move:
3.37%
Buy
77
SYRE
Spyre Therapeutics
Last Price:
33.64
Seasonality Move:
2.56%
Sell
42
L'Oreal SA (LRLCY)
is a Sell
Is L'Oreal SA a Buy, Sell or Hold?
- The current L'Oreal SA [LRLCY] share price is $76.96. The Score for LRLCY is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- LRLCY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
77
Spyre Therapeutics (SYRE)
is a Buy
Is Spyre Therapeutics a Buy, Sell or Hold?
- The current Spyre Therapeutics [SYRE] share price is $33.61. The Score for SYRE is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
- SYRE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LRLCY Stock Price Chart
What is L'Oreal SA's stock price today?
-
The L'Oreal SA share price today is $76.96
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LRLCY is experiencing slight buying pressure.
SYRE Stock Price Chart
What is Spyre Therapeutics's stock price today?
-
The Spyre Therapeutics share price today is $33.61
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SYRE is experiencing slight buying pressure.
LRLCY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.94 | Sell |
| Relative Strength Index (14 RSI): | 33.01 | Sell |
| Chaikin Money Flow: | 44387 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (80.49 - 88.13) | Sell |
| Bollinger Bands (100): | (82.35 - 92.51) | Sell |
SYRE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.31 | Buy |
| Relative Strength Index (14 RSI): | 65.97 | Buy |
| Chaikin Money Flow: | 71576 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.6 - 31.68) | Buy |
| Bollinger Bands (100): | (25.36 - 31.92) | Buy |
LRLCY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 80.72 | Sell |
| 20-day SMA: | 84.57 | Sell |
| 50-day SMA: | 84.69 | Sell |
| 200-day SMA: | 91.17 | Sell |
| 8-day EMA: | 79.97 | Sell |
| 20-day EMA: | 82.62 | Sell |
| 50-day EMA: | 84.58 | Sell |
| 200-day EMA: | 88.63 | Sell |
SYRE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.02 | Buy |
| 20-day SMA: | 29.67 | Buy |
| 50-day SMA: | 28.54 | Buy |
| 200-day SMA: | 30.33 | Buy |
| 8-day EMA: | 32.12 | Buy |
| 20-day EMA: | 30.47 | Buy |
| 50-day EMA: | 29.32 | Buy |
| 200-day EMA: | 27.79 | Buy |
L'Oreal SA Earnings Growth & LRLCY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Spyre Therapeutics Earnings Growth & SYRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.01 per share, and a decrease next year of $0.09 per share.
L'Oreal SA Technical Analysis
| Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Spyre Therapeutics Technical Analysis
| Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||